AstraZeneca was exposed to divest heavy breathing products, set up a new company to take over
Recently, industry sources said that AstraZeneca will form a new company with a "Chinese" investment company, and AstraZeneca will transfer its respiratory product line to this new company, and complete the staff signing before July 1.
According to analysts, AstraZeneca spun off the new company mainly because of the impact of pooling. Due to the contraction of profits, the related products will gradually become the company's non-core assets, and the newly established company mainly manages some of the collected product lines divested by the company, and more collected products are expected to be transferred in the future, such as the digestion product line.
2026-09-19
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
AstraZeneca and CSPC Strengthen Biologics Manufacturing Partnership in China
-
China's Ibuprofen Export Performance, First Half of 2026
-
AstraZeneca Pays Up to $1.5 Billion for Global Rights to Chinese Lung Cancer Drug
-
Germany Passes Healthcare Reform, Multinational Drugmakers Face 15.5% Mandatory Discount
-
AstraZeneca’s Wainua Fails Phase III Heart Trial, Wiping Out About $27 Billion in Market Value
-
$15 Billion Invested in China: AstraZeneca Builds an “Innovation Hub” While Some Are Still Waiting for the Windfall
-
AstraZeneca to Invest $2 Billion in New U.S. Biologics Facilities
-
The relationship between Digital Transformation and Work- Life Balance in the Egyptian Pharmaceutical Industry
-
AstraZeneca to Invest $2.5 Billion to Establish Global Drug R&D Center in Beijing
-
AstraZeneca to invest $3.5 billion in the United States
Recommend Reading
-
From LANXESS’s 50% to Tire Makers’ 5%: The Rubber Industry Chain Is Experiencing a “Decreasing-Cost Transmission”
-
NHU and Sinopec Advance Liquid Methionine Project
-
BASF and Nihon Nohyaku Partner for Fruit Crop Protection in Japan
-
An Explosion Has Occurred in the Jubail Industrial City, Putting 6–8% of Global Petrochemical Production Capacity at Risk
-
AkzoNobel Invests €50 Million to Expand Aerospace Coatings Operations in the United States
-
On March 11, the Chinese acrylonitrile market remained stable and organized
-
On March 11, the pure benzene market in China continued to see a significant decrease
-
Dual Production Areas Have Maintenance Plans, Formic Acid Prices Rise Strongly
-
Both Supply and Demand Increase, Lithium Carbonate Rides Out Volatility
-
This week, the domestic acetic acid market has seen a slight increase